EUVIMEDEUVIMED entdecken
Crossref

Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia

Journal of Chinese Pharmaceutical Sciences · 30.05.2026 · 35 (5) · 491

DOI: 10.5246/jcps.2026.05.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia. Journal of Chinese Pharmaceutical Sciences, 35(5), 491. https://doi.org/10.5246/jcps.2026.05.035

Vancouver

Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia. Journal of Chinese Pharmaceutical Sciences. 2026;35(5):491. doi:10.5246/jcps.2026.05.035

BibTeX
@article{euvimed2026,
  title = {Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia},
  journal = {Journal of Chinese Pharmaceutical Sciences},
  year = {2026},
  volume = {35},
  number = {5},
  pages = {491},
  doi = {10.5246/jcps.2026.05.035}
}
Kostenlos starten →